Chromatographic techniques for the characterization of CQAs in biosimilars

Critical to the development and commercialization of a biosimilar is understanding the originator and how its CQAs compare against those of the biosimilar.

Learn more about our solutions that provide high quality peptide mapping, glycan and charge variant data.

Presenter: Andrew Argo (Strategic Marketing Lead, Waters Corporation)

Andrew has held positions across industry with a focus on analytical method development for LC and LCMS applications for products ranging from peptides to gene therapy for almost 10 years. He is currently the strategic marketing lead for the biopharma and new modality portfolios within the chemistry organization, helping to understand these evolving therapeutic areas and customer needs.